China’s Lenovo Group Ltd has resumed talks to buy International Business Machines Corp. (NYSE:IBM) low-end server unit, a source familiar with the matter said, a purchase that would bolster its efforts to diversify beyond a shrinking PC market. International Business Machines Corp. (NYSE:IBM) stock rose 0.70% and finished the last session at $190.09. The EPS of the stock remained 14.47. Company’s market capitalization is $206.41 billion.
Prima Biomed Ltd. (NASDAQ:PBMD) announced that the amended CAN-004 protocol was approved by the Belgian Federal Agency for Medicines and Health Products. This is the first regulatory agency to approve the amended CVac™ clinical trial design. CAN-004 is a multicentre, randomized, phase 2 trial of CVac for the maintenance treatment of epithelial ovarian cancer in remission. Prima Biomed Ltd. (NASDAQ:PBMD) stock opened at $1.65 in last trading session and closed at $1.43. The 52 week range of the stock is $0.82 – $4.54 and the day range was $1.40 – $1.65.
When Morgan Stanley (NYSE:MS) reported fourth-quarter earnings on Friday that were weighed down by an unusually large legal charge, investors took the hit in stride and sent the company’s shares up anyway. Many analysts — including Thomson Reuters, which polls analyst estimates — categorized Morgan Stanley’s full $1.2 billion legal expense as a one-time item. Stripping out the legal charge, a tax benefit and accounting adjustments, Morgan Stanley logged 50 cents in per-share profit, five cents above the consensus estimate of analysts polled by Thomson. Morgan Stanley (NYSE:MS) shares closed at $33.40 on last trade day, by gaining 4.38%. Stock 52 week range is $20.16 – $33.52. Company’s market capitalization is $65.17 billion.
Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) announced the commercial availability of Iclusig® (ponatinib) for adult patients with refractory chronic myeloid leukemia and Philadelphia-chromosome positive acute lymphoblastic leukemia in the United States. ARIAD has begun shipping Iclusig to Biologics, Inc., its exclusive specialty pharmacy, which is now filling prescriptions from physicians and distributing the cancer medicine to patients. Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) stock opened at $7.24 in last trading session, and closed at $6.90, trading in the range of $6.89 – $7.35. The stock showed a positive weekly performance of 2.53%.